Status:
COMPLETED
Therapeutic Drug Monitoring of Antifungals in Intensive Care Units
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Intensive Care Unit Patients
Eligibility:
All Genders
16+ years
Brief Summary
Antifungals under- and over-dosing are frequently deplored in patients treated with antifungals and receiving recommended doses, mostly in critically-ill patients. This situation is well-described for...
Eligibility Criteria
Inclusion
- Adult patients who received antifungals including fluconazole, voriconazole, posaconazole, or caspofungin, during their ICU stay and had a Therapeutic Drug Monitoring (TDM)
Exclusion
- Patients without antifungal treatment
- Patients who received an antifungal combination
- Pediatric patients
- Patients who were not admitted in ICU
- Patients who did not have a TDM
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04502771
Start Date
January 1 2018
End Date
December 31 2019
Last Update
August 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospices Civils de Lyon, Croix-Rousse Hospital
Lyon, France, 69004